Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 5.73256878 |
2 | central nervous system myelination (GO:0022010) | 5.73256878 |
3 | protein maturation by protein folding (GO:0022417) | 4.67445022 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.64319163 |
5 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.60462606 |
6 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.34656099 |
7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.26983371 |
8 | ATP synthesis coupled proton transport (GO:0015986) | 4.26983371 |
9 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.25024219 |
10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.20838846 |
11 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.13600623 |
12 | establishment of integrated proviral latency (GO:0075713) | 4.10214656 |
13 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.07805999 |
14 | negative regulation of ligase activity (GO:0051352) | 4.07805999 |
15 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.03020331 |
16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.01295489 |
17 | creatine metabolic process (GO:0006600) | 3.90259365 |
18 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.85503382 |
19 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.83385754 |
20 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.83136759 |
21 | ribosome assembly (GO:0042255) | 3.76879784 |
22 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.73524326 |
23 | regulation of mitochondrial translation (GO:0070129) | 3.73396005 |
24 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.68527626 |
25 | respiratory electron transport chain (GO:0022904) | 3.65782252 |
26 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.61813191 |
27 | establishment of viral latency (GO:0019043) | 3.58822305 |
28 | negative regulation of neurotransmitter transport (GO:0051589) | 3.57873597 |
29 | positive regulation of ligase activity (GO:0051351) | 3.57229318 |
30 | regulation of cofactor metabolic process (GO:0051193) | 3.53511648 |
31 | regulation of coenzyme metabolic process (GO:0051196) | 3.53511648 |
32 | electron transport chain (GO:0022900) | 3.53424302 |
33 | COPI coating of Golgi vesicle (GO:0048205) | 3.51988919 |
34 | Golgi transport vesicle coating (GO:0048200) | 3.51988919 |
35 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.50921208 |
36 | DNA deamination (GO:0045006) | 3.49650059 |
37 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.44211334 |
38 | proteasome assembly (GO:0043248) | 3.42498927 |
39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.41756007 |
40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.41756007 |
41 | oxidative phosphorylation (GO:0006119) | 3.41396615 |
42 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.40989118 |
43 | termination of RNA polymerase III transcription (GO:0006386) | 3.40989118 |
44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.39718985 |
45 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.39718985 |
46 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.39718985 |
47 | regulation of ligase activity (GO:0051340) | 3.38119057 |
48 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.36893239 |
49 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.36893239 |
50 | cholesterol biosynthetic process (GO:0006695) | 3.29390576 |
51 | protein neddylation (GO:0045116) | 3.28626715 |
52 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.28288690 |
53 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.26748462 |
54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.26748462 |
55 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.26748462 |
56 | mitotic sister chromatid segregation (GO:0000070) | 3.20728007 |
57 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.19983253 |
58 | cullin deneddylation (GO:0010388) | 3.19729598 |
59 | transcription from mitochondrial promoter (GO:0006390) | 3.18657102 |
60 | protein localization to kinetochore (GO:0034501) | 3.16238334 |
61 | NADH metabolic process (GO:0006734) | 3.12827087 |
62 | protein localization to mitochondrion (GO:0070585) | 3.12384628 |
63 | protein localization to chromosome, centromeric region (GO:0071459) | 3.10480145 |
64 | signal peptide processing (GO:0006465) | 3.09664048 |
65 | IMP biosynthetic process (GO:0006188) | 3.08429162 |
66 | establishment of chromosome localization (GO:0051303) | 3.07117466 |
67 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.06549471 |
68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06333447 |
69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.05651259 |
70 | protein deneddylation (GO:0000338) | 3.04860634 |
71 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.02032989 |
72 | axon ensheathment (GO:0008366) | 3.01035720 |
73 | ensheathment of neurons (GO:0007272) | 3.01035720 |
74 | fatty acid elongation (GO:0030497) | 3.00846831 |
75 | cell cycle G1/S phase transition (GO:0044843) | 2.94234949 |
76 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.94234949 |
77 | myelination (GO:0042552) | 2.93166968 |
78 | DNA replication initiation (GO:0006270) | 2.90815671 |
79 | ribosomal large subunit biogenesis (GO:0042273) | 2.89970995 |
80 | mitotic nuclear envelope disassembly (GO:0007077) | 2.89525570 |
81 | negative regulation of protein ubiquitination (GO:0031397) | 2.89481963 |
82 | chaperone-mediated protein transport (GO:0072321) | 2.88991187 |
83 | regulation of translational termination (GO:0006449) | 2.84943505 |
84 | ubiquinone metabolic process (GO:0006743) | 2.84567234 |
85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84459541 |
86 | de novo protein folding (GO:0006458) | 2.84384358 |
87 | nuclear pore complex assembly (GO:0051292) | 2.82966117 |
88 | DNA unwinding involved in DNA replication (GO:0006268) | 2.82940402 |
89 | AMP metabolic process (GO:0046033) | 2.82444642 |
90 | sterol biosynthetic process (GO:0016126) | 2.80810010 |
91 | L-methionine salvage (GO:0071267) | 2.79841045 |
92 | L-methionine biosynthetic process (GO:0071265) | 2.79841045 |
93 | amino acid salvage (GO:0043102) | 2.79841045 |
94 | spliceosomal snRNP assembly (GO:0000387) | 2.78032310 |
95 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.77934138 |
96 | purine nucleobase biosynthetic process (GO:0009113) | 2.77838807 |
97 | establishment of mitochondrion localization (GO:0051654) | 2.77175442 |
98 | positive regulation of cell cycle arrest (GO:0071158) | 2.76418808 |
99 | sister chromatid segregation (GO:0000819) | 2.74803637 |
100 | regulation of sulfur metabolic process (GO:0042762) | 2.74586342 |
101 | pseudouridine synthesis (GO:0001522) | 2.74507089 |
102 | ventricular cardiac muscle cell development (GO:0055015) | 2.73539266 |
103 | telomere maintenance via recombination (GO:0000722) | 2.73333570 |
104 | quinone biosynthetic process (GO:1901663) | 2.72404394 |
105 | ubiquinone biosynthetic process (GO:0006744) | 2.72404394 |
106 | neutrophil activation involved in immune response (GO:0002283) | 2.71918156 |
107 | maturation of 5.8S rRNA (GO:0000460) | 2.71691432 |
108 | mitotic metaphase plate congression (GO:0007080) | 2.71634526 |
109 | rRNA modification (GO:0000154) | 2.71544086 |
110 | mitotic nuclear envelope reassembly (GO:0007084) | 2.71137646 |
111 | nuclear envelope reassembly (GO:0031468) | 2.71137646 |
112 | nuclear envelope disassembly (GO:0051081) | 2.69926180 |
113 | membrane disassembly (GO:0030397) | 2.69926180 |
114 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.69606068 |
115 | de novo posttranslational protein folding (GO:0051084) | 2.69158440 |
116 | tRNA aminoacylation for protein translation (GO:0006418) | 2.69011562 |
117 | regulation of cellular amine metabolic process (GO:0033238) | 2.68801409 |
118 | isoprenoid biosynthetic process (GO:0008299) | 2.68615413 |
119 | peptidyl-histidine modification (GO:0018202) | 2.67030282 |
120 | sarcomere organization (GO:0045214) | 2.66249241 |
121 | tRNA aminoacylation (GO:0043039) | 2.65987439 |
122 | amino acid activation (GO:0043038) | 2.65987439 |
123 | IMP metabolic process (GO:0046040) | 2.65705983 |
124 | rRNA processing (GO:0006364) | 2.58461967 |
125 | rRNA methylation (GO:0031167) | 2.53969164 |
126 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.53964680 |
127 | N-terminal protein amino acid modification (GO:0031365) | 2.51899599 |
128 | tricarboxylic acid cycle (GO:0006099) | 2.49445462 |
129 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.48942658 |
130 | DNA strand elongation (GO:0022616) | 2.48222094 |
131 | metaphase plate congression (GO:0051310) | 2.46899300 |
132 | regulation of relaxation of muscle (GO:1901077) | 2.46301831 |
133 | nucleobase biosynthetic process (GO:0046112) | 2.45984742 |
134 | CENP-A containing nucleosome assembly (GO:0034080) | 2.45657913 |
135 | rRNA metabolic process (GO:0016072) | 2.45028130 |
136 | tissue regeneration (GO:0042246) | 2.44224569 |
137 | protein complex biogenesis (GO:0070271) | 2.43616306 |
138 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.43487620 |
139 | nucleotide transmembrane transport (GO:1901679) | 2.43461313 |
140 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.42861859 |
141 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.42806249 |
142 | cellular response to nicotine (GO:0071316) | 2.42026758 |
143 | maturation of SSU-rRNA (GO:0030490) | 2.41296841 |
144 | formation of translation preinitiation complex (GO:0001731) | 2.40886713 |
145 | establishment of protein localization to mitochondrion (GO:0072655) | 2.40774762 |
146 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.38443747 |
147 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.38314324 |
148 | protein targeting to mitochondrion (GO:0006626) | 2.38145527 |
149 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.37076498 |
150 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37033950 |
151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37033950 |
152 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.36728307 |
153 | ribosomal small subunit biogenesis (GO:0042274) | 2.35621095 |
154 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.35024734 |
155 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.34599917 |
156 | chromatin remodeling at centromere (GO:0031055) | 2.34092465 |
157 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.33803036 |
158 | isotype switching (GO:0045190) | 2.33803036 |
159 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.33803036 |
160 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.33410800 |
161 | negative regulation of protein localization to cell surface (GO:2000009) | 2.33099894 |
162 | regulation of pigment cell differentiation (GO:0050932) | 2.30651531 |
163 | DNA replication checkpoint (GO:0000076) | 2.30476704 |
164 | mitotic recombination (GO:0006312) | 2.30092421 |
165 | myelin maintenance (GO:0043217) | 2.29756162 |
166 | regulation of actin filament-based movement (GO:1903115) | 2.28630928 |
167 | ribosome biogenesis (GO:0042254) | 2.28101891 |
168 | mitotic chromosome condensation (GO:0007076) | 2.27356386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.31194143 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.16526764 |
3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.16025534 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.87614973 |
5 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.65260030 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.55760204 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.00127053 |
8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85328998 |
9 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.81933865 |
10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.78351246 |
11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.75129601 |
12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.70753307 |
13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.69782795 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64545144 |
15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.55213463 |
16 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.50577653 |
17 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.45101364 |
18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43491145 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33818748 |
20 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.27868257 |
21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23390698 |
22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20379250 |
23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14372027 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.09417602 |
25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.09103570 |
26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08869326 |
27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.07791885 |
28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.07437050 |
29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04682938 |
30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99180719 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96874269 |
32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94398834 |
33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89285038 |
34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87711030 |
35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77329985 |
36 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.76963708 |
37 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76607691 |
38 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75857684 |
39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75285311 |
40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70540402 |
41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.70285928 |
42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.70016921 |
43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69988025 |
44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65016135 |
45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.64314173 |
46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60931957 |
47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60743532 |
48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58691542 |
49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55817868 |
50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.55436438 |
51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53183613 |
52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51051168 |
53 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50635407 |
54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48830423 |
55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48352848 |
56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47149829 |
57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45774032 |
58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44959483 |
59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44067956 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43742393 |
61 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.42600083 |
62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42152563 |
63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38854675 |
64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37286803 |
65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36577451 |
66 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34522407 |
67 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.33092577 |
68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32832332 |
69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32026671 |
70 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30590628 |
71 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30052823 |
72 | MYB_26560356_Chip-Seq_TH2_Human | 1.27227144 |
73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27097795 |
74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24864858 |
75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24821188 |
76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23942158 |
77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22639853 |
78 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22391995 |
79 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22052884 |
80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21612902 |
81 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.21078515 |
82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20924205 |
83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20684094 |
84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18698082 |
85 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18256741 |
86 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18151933 |
87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17778762 |
88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17050133 |
89 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16512957 |
90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15060723 |
91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14948341 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14745464 |
93 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.12387578 |
94 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11810705 |
95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11478866 |
96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10699020 |
97 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10210377 |
98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09886701 |
99 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09355632 |
100 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08657370 |
101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07646647 |
102 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06881445 |
103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06332357 |
104 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04779321 |
105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03238225 |
106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02782715 |
107 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01095470 |
108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00437143 |
109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00132395 |
110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98976261 |
111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98112048 |
112 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97719150 |
113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97460004 |
114 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95743981 |
115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95731759 |
116 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.95207703 |
117 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95199107 |
118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95009004 |
119 | MYB_26560356_Chip-Seq_TH1_Human | 0.94850925 |
120 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92398143 |
121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92068113 |
122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90084335 |
123 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89675500 |
124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89642692 |
125 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.89546757 |
126 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89363971 |
127 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89342304 |
128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89299925 |
129 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.87604546 |
130 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87074642 |
131 | FUS_26573619_Chip-Seq_HEK293_Human | 0.85758593 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008057_abnormal_DNA_replication | 3.46049735 |
2 | MP0003646_muscle_fatigue | 2.71969075 |
3 | MP0004084_abnormal_cardiac_muscle | 2.70385085 |
4 | MP0002837_dystrophic_cardiac_calcinosis | 2.64846503 |
5 | MP0003221_abnormal_cardiomyocyte_apopto | 2.57337742 |
6 | MP0000920_abnormal_myelination | 2.57212385 |
7 | MP0004233_abnormal_muscle_weight | 2.38697570 |
8 | MP0009697_abnormal_copulation | 2.38448621 |
9 | MP0005451_abnormal_body_composition | 2.34125765 |
10 | MP0010234_abnormal_vibrissa_follicle | 2.22456449 |
11 | MP0003941_abnormal_skin_development | 2.21040244 |
12 | * MP0005330_cardiomyopathy | 2.18475915 |
13 | MP0003136_yellow_coat_color | 2.13769126 |
14 | MP0003786_premature_aging | 2.13269639 |
15 | MP0003806_abnormal_nucleotide_metabolis | 2.11929966 |
16 | MP0004036_abnormal_muscle_relaxation | 2.11330546 |
17 | MP0001529_abnormal_vocalization | 2.11194277 |
18 | * MP0006036_abnormal_mitochondrial_physio | 2.02264168 |
19 | MP0003950_abnormal_plasma_membrane | 1.99015973 |
20 | MP0000749_muscle_degeneration | 1.93848614 |
21 | MP0003724_increased_susceptibility_to | 1.92067270 |
22 | * MP0004215_abnormal_myocardial_fiber | 1.91357651 |
23 | MP0003828_pulmonary_edema | 1.90644352 |
24 | MP0004957_abnormal_blastocyst_morpholog | 1.89643737 |
25 | MP0000747_muscle_weakness | 1.85835330 |
26 | MP0009333_abnormal_splenocyte_physiolog | 1.80354548 |
27 | MP0005671_abnormal_response_to | 1.77619881 |
28 | MP0000465_gastrointestinal_hemorrhage | 1.75276804 |
29 | MP0006035_abnormal_mitochondrial_morpho | 1.64378663 |
30 | MP0010352_gastrointestinal_tract_polyps | 1.61493743 |
31 | MP0005000_abnormal_immune_tolerance | 1.59179727 |
32 | MP0000358_abnormal_cell_content/ | 1.57147765 |
33 | MP0003693_abnormal_embryo_hatching | 1.56494937 |
34 | MP0008260_abnormal_autophagy | 1.54854299 |
35 | MP0001835_abnormal_antigen_presentation | 1.50006739 |
36 | MP0001485_abnormal_pinna_reflex | 1.47118744 |
37 | MP0000751_myopathy | 1.46400150 |
38 | MP0010094_abnormal_chromosome_stability | 1.46314935 |
39 | * MP0002106_abnormal_muscle_physiology | 1.45627186 |
40 | MP0003077_abnormal_cell_cycle | 1.45088051 |
41 | MP0002796_impaired_skin_barrier | 1.44738157 |
42 | MP0009379_abnormal_foot_pigmentation | 1.44526606 |
43 | MP0003111_abnormal_nucleus_morphology | 1.42347281 |
44 | MP0004145_abnormal_muscle_electrophysio | 1.42025853 |
45 | MP0003566_abnormal_cell_adhesion | 1.41986020 |
46 | MP0001697_abnormal_embryo_size | 1.41628055 |
47 | MP0000750_abnormal_muscle_regeneration | 1.38032156 |
48 | MP0004087_abnormal_muscle_fiber | 1.35690273 |
49 | MP0001348_abnormal_lacrimal_gland | 1.35140671 |
50 | MP0005501_abnormal_skin_physiology | 1.34988305 |
51 | MP0010030_abnormal_orbit_morphology | 1.34852598 |
52 | MP0006082_CNS_inflammation | 1.32059923 |
53 | * MP0002080_prenatal_lethality | 1.31258557 |
54 | MP0008932_abnormal_embryonic_tissue | 1.30616868 |
55 | MP0004147_increased_porphyrin_level | 1.30585309 |
56 | MP0010307_abnormal_tumor_latency | 1.30046151 |
57 | * MP0001672_abnormal_embryogenesis/_devel | 1.29857886 |
58 | * MP0005380_embryogenesis_phenotype | 1.29857886 |
59 | MP0002163_abnormal_gland_morphology | 1.29472283 |
60 | MP0002972_abnormal_cardiac_muscle | 1.28087468 |
61 | MP0000313_abnormal_cell_death | 1.27195763 |
62 | MP0004510_myositis | 1.25829576 |
63 | MP0009840_abnormal_foam_cell | 1.25660433 |
64 | MP0009785_altered_susceptibility_to | 1.25142347 |
65 | MP0001188_hyperpigmentation | 1.24001659 |
66 | MP0002396_abnormal_hematopoietic_system | 1.22797070 |
67 | MP0004484_altered_response_of | 1.20454773 |
68 | MP0008007_abnormal_cellular_replicative | 1.19869823 |
69 | MP0004043_abnormal_pH_regulation | 1.19702164 |
70 | * MP0003984_embryonic_growth_retardation | 1.17513302 |
71 | MP0008775_abnormal_heart_ventricle | 1.17224066 |
72 | MP0003303_peritoneal_inflammation | 1.16793302 |
73 | MP0002332_abnormal_exercise_endurance | 1.15296367 |
74 | MP0008438_abnormal_cutaneous_collagen | 1.15086411 |
75 | MP0001800_abnormal_humoral_immune | 1.13391940 |
76 | * MP0005369_muscle_phenotype | 1.13068482 |
77 | MP0002723_abnormal_immune_serum | 1.11542372 |
78 | * MP0002088_abnormal_embryonic_growth/wei | 1.10601735 |
79 | MP0004142_abnormal_muscle_tone | 1.09321005 |
80 | MP0004130_abnormal_muscle_cell | 1.09313582 |
81 | MP0003763_abnormal_thymus_physiology | 1.09283836 |
82 | MP0003186_abnormal_redox_activity | 1.08953920 |
83 | MP0005620_abnormal_muscle_contractility | 1.08054986 |
84 | MP0001790_abnormal_immune_system | 1.07732316 |
85 | MP0005387_immune_system_phenotype | 1.07732316 |
86 | MP0003705_abnormal_hypodermis_morpholog | 1.07182521 |
87 | MP0002420_abnormal_adaptive_immunity | 1.06248291 |
88 | MP0002452_abnormal_antigen_presenting | 1.05399182 |
89 | MP0002933_joint_inflammation | 1.04938162 |
90 | MP0009672_abnormal_birth_weight | 1.04518116 |
91 | MP0002148_abnormal_hypersensitivity_rea | 1.04339443 |
92 | MP0002398_abnormal_bone_marrow | 1.04258224 |
93 | MP0001819_abnormal_immune_cell | 1.03712264 |
94 | MP0005408_hypopigmentation | 1.03088707 |
95 | * MP0003137_abnormal_impulse_conducting | 1.02239571 |
96 | MP0004272_abnormal_basement_membrane | 1.01634084 |
97 | MP0000759_abnormal_skeletal_muscle | 1.00765193 |
98 | MP0005058_abnormal_lysosome_morphology | 1.00594667 |
99 | MP0002060_abnormal_skin_morphology | 1.00327288 |
100 | MP0000343_altered_response_to | 0.99811415 |
101 | MP0000490_abnormal_crypts_of | 0.99429541 |
102 | MP0001881_abnormal_mammary_gland | 0.99066360 |
103 | MP0002009_preneoplasia | 0.98850726 |
104 | MP0004185_abnormal_adipocyte_glucose | 0.97029762 |
105 | MP0003690_abnormal_glial_cell | 0.96892410 |
106 | MP0001730_embryonic_growth_arrest | 0.96700197 |
107 | MP0002877_abnormal_melanocyte_morpholog | 0.96590342 |
108 | MP0001727_abnormal_embryo_implantation | 0.95333121 |
109 | * MP0005385_cardiovascular_system_phenoty | 0.94226364 |
110 | * MP0001544_abnormal_cardiovascular_syste | 0.94226364 |
111 | MP0001243_abnormal_dermal_layer | 0.93976122 |
112 | MP0003436_decreased_susceptibility_to | 0.93432434 |
113 | MP0000372_irregular_coat_pigmentation | 0.93380184 |
114 | MP0000716_abnormal_immune_system | 0.93237182 |
115 | MP0002419_abnormal_innate_immunity | 0.93140408 |
116 | MP0001661_extended_life_span | 0.92884274 |
117 | MP0010630_abnormal_cardiac_muscle | 0.92510759 |
118 | MP0005623_abnormal_meninges_morphology | 0.92395229 |
119 | MP0004742_abnormal_vestibular_system | 0.92221318 |
120 | MP0008877_abnormal_DNA_methylation | 0.91387599 |
121 | MP0002086_abnormal_extraembryonic_tissu | 0.90929651 |
122 | MP0003656_abnormal_erythrocyte_physiolo | 0.90609094 |
123 | MP0008058_abnormal_DNA_repair | 0.90323852 |
124 | MP0005384_cellular_phenotype | 0.89975894 |
125 | MP0003123_paternal_imprinting | 0.89580771 |
126 | MP0000350_abnormal_cell_proliferation | 0.88922678 |
127 | MP0000689_abnormal_spleen_morphology | 0.88482794 |
128 | MP0000013_abnormal_adipose_tissue | 0.86675014 |
129 | MP0002405_respiratory_system_inflammati | 0.86021965 |
130 | MP0002269_muscular_atrophy | 0.84352389 |
131 | MP0003718_maternal_effect | 0.83906414 |
132 | MP0003191_abnormal_cellular_cholesterol | 0.83813117 |
133 | MP0002085_abnormal_embryonic_tissue | 0.83673348 |
134 | MP0005165_increased_susceptibility_to | 0.83637795 |
135 | MP0001853_heart_inflammation | 0.83453347 |
136 | MP0005025_abnormal_response_to | 0.83157268 |
137 | MP0001905_abnormal_dopamine_level | 0.82827186 |
138 | MP0005266_abnormal_metabolism | 0.82450226 |
139 | MP0002210_abnormal_sex_determination | 0.79533720 |
140 | MP0005083_abnormal_biliary_tract | 0.79236974 |
141 | MP0005621_abnormal_cell_physiology | 0.78286792 |
142 | MP0002019_abnormal_tumor_incidence | 0.76770581 |
143 | MP0001764_abnormal_homeostasis | 0.76260920 |
144 | MP0000003_abnormal_adipose_tissue | 0.76206161 |
145 | * MP0002084_abnormal_developmental_patter | 0.73308546 |
146 | MP0001216_abnormal_epidermal_layer | 0.72668310 |
147 | MP0003453_abnormal_keratinocyte_physiol | 0.72620210 |
148 | MP0001929_abnormal_gametogenesis | 0.67417374 |
149 | MP0002139_abnormal_hepatobiliary_system | 0.67301311 |
150 | MP0005319_abnormal_enzyme/_coenzyme | 0.65339615 |
151 | MP0000627_abnormal_mammary_gland | 0.64918633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolysis (HP:0004366) | 4.93822372 |
2 | Increased serum pyruvate (HP:0003542) | 4.93822372 |
3 | Acute necrotizing encephalopathy (HP:0006965) | 4.25695411 |
4 | Hepatocellular necrosis (HP:0001404) | 4.25433735 |
5 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.21360569 |
6 | Abnormality of alanine metabolism (HP:0010916) | 4.21360569 |
7 | Hyperalaninemia (HP:0003348) | 4.21360569 |
8 | Hepatic necrosis (HP:0002605) | 4.06072469 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.83818688 |
10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.75286636 |
11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.75286636 |
12 | Mitochondrial inheritance (HP:0001427) | 3.74550188 |
13 | Increased CSF lactate (HP:0002490) | 3.59169326 |
14 | Cerebral hypomyelination (HP:0006808) | 3.56740370 |
15 | Muscle fiber splitting (HP:0003555) | 3.50619668 |
16 | Acute encephalopathy (HP:0006846) | 3.49070696 |
17 | Progressive macrocephaly (HP:0004481) | 3.22530927 |
18 | Ragged-red muscle fibers (HP:0003200) | 3.22148514 |
19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.15854240 |
20 | Exercise-induced muscle cramps (HP:0003710) | 3.10648503 |
21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.96980391 |
22 | Lipid accumulation in hepatocytes (HP:0006561) | 2.94599322 |
23 | Peripheral hypomyelination (HP:0007182) | 2.86079832 |
24 | Postnatal microcephaly (HP:0005484) | 2.79585246 |
25 | Rhabdomyolysis (HP:0003201) | 2.75312178 |
26 | Nemaline bodies (HP:0003798) | 2.74707539 |
27 | Leukodystrophy (HP:0002415) | 2.74205517 |
28 | CNS hypomyelination (HP:0003429) | 2.73599205 |
29 | Respiratory failure (HP:0002878) | 2.72883885 |
30 | Increased serum lactate (HP:0002151) | 2.71497410 |
31 | Shoulder girdle muscle weakness (HP:0003547) | 2.68941773 |
32 | Cerebral edema (HP:0002181) | 2.67386886 |
33 | Exertional dyspnea (HP:0002875) | 2.66026460 |
34 | Exercise intolerance (HP:0003546) | 2.64941566 |
35 | Progressive muscle weakness (HP:0003323) | 2.64713176 |
36 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.63404441 |
37 | Muscle fiber inclusion bodies (HP:0100299) | 2.61350281 |
38 | Degeneration of anterior horn cells (HP:0002398) | 2.53610196 |
39 | Abnormality of the anterior horn cell (HP:0006802) | 2.53610196 |
40 | Progressive external ophthalmoplegia (HP:0000590) | 2.49762308 |
41 | Lactic acidosis (HP:0003128) | 2.49081573 |
42 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48491583 |
43 | Entropion (HP:0000621) | 2.46017845 |
44 | Distal lower limb muscle weakness (HP:0009053) | 2.45958744 |
45 | Termporal pattern (HP:0011008) | 2.44681561 |
46 | Insidious onset (HP:0003587) | 2.44681561 |
47 | CNS demyelination (HP:0007305) | 2.43891268 |
48 | Rough bone trabeculation (HP:0100670) | 2.43424448 |
49 | Cerebral hemorrhage (HP:0001342) | 2.42869215 |
50 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.42408496 |
51 | Calf muscle hypertrophy (HP:0008981) | 2.40751093 |
52 | Abnormality of the corticospinal tract (HP:0002492) | 2.40203884 |
53 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.39980927 |
54 | Single umbilical artery (HP:0001195) | 2.39980927 |
55 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.39980927 |
56 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.39405063 |
57 | Myopathic facies (HP:0002058) | 2.38534994 |
58 | Respiratory difficulties (HP:0002880) | 2.38443943 |
59 | Trismus (HP:0000211) | 2.36867278 |
60 | Neuroendocrine neoplasm (HP:0100634) | 2.36391706 |
61 | Sparse eyelashes (HP:0000653) | 2.34287546 |
62 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.31908305 |
63 | Microvesicular hepatic steatosis (HP:0001414) | 2.30242438 |
64 | Parakeratosis (HP:0001036) | 2.29801031 |
65 | Abnormality of placental membranes (HP:0011409) | 2.29790029 |
66 | Amniotic constriction ring (HP:0009775) | 2.29790029 |
67 | Type 1 muscle fiber predominance (HP:0003803) | 2.27414813 |
68 | Pelvic girdle muscle weakness (HP:0003749) | 2.27189057 |
69 | Pheochromocytoma (HP:0002666) | 2.26178846 |
70 | Type I transferrin isoform profile (HP:0003642) | 2.26112959 |
71 | Reduced antithrombin III activity (HP:0001976) | 2.26109380 |
72 | Autoamputation (HP:0001218) | 2.25015657 |
73 | Cholecystitis (HP:0001082) | 2.24401316 |
74 | Abnormal gallbladder physiology (HP:0012438) | 2.24401316 |
75 | Prolonged neonatal jaundice (HP:0006579) | 2.23305877 |
76 | Cutaneous melanoma (HP:0012056) | 2.22995835 |
77 | Increased muscle lipid content (HP:0009058) | 2.22988979 |
78 | Renal Fanconi syndrome (HP:0001994) | 2.22079956 |
79 | Hepatosplenomegaly (HP:0001433) | 2.20571683 |
80 | Poor head control (HP:0002421) | 2.19861222 |
81 | Tetraparesis (HP:0002273) | 2.17123126 |
82 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.16007517 |
83 | Palpitations (HP:0001962) | 2.13299496 |
84 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13159225 |
85 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12080376 |
86 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12080376 |
87 | Exercise-induced myalgia (HP:0003738) | 2.11784170 |
88 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.10181743 |
89 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.10181743 |
90 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.09753973 |
91 | Abnormality of methionine metabolism (HP:0010901) | 2.09655561 |
92 | Microretrognathia (HP:0000308) | 2.09027123 |
93 | Nausea (HP:0002018) | 2.08776653 |
94 | Premature ovarian failure (HP:0008209) | 2.08671238 |
95 | Abnormality of the umbilical cord (HP:0010881) | 2.05674755 |
96 | Dilated cardiomyopathy (HP:0001644) | 2.05559616 |
97 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05037345 |
98 | Increased connective tissue (HP:0009025) | 2.04710625 |
99 | Stomatitis (HP:0010280) | 2.03153308 |
100 | Aplastic anemia (HP:0001915) | 2.02685009 |
101 | Myoglobinuria (HP:0002913) | 2.00799956 |
102 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99764042 |
103 | Muscle stiffness (HP:0003552) | 1.98435603 |
104 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97073038 |
105 | EMG: myopathic abnormalities (HP:0003458) | 1.96715435 |
106 | Abnormal trabecular bone morphology (HP:0100671) | 1.96119967 |
107 | IgM deficiency (HP:0002850) | 1.95779765 |
108 | IgG deficiency (HP:0004315) | 1.95485634 |
109 | Multiple enchondromatosis (HP:0005701) | 1.95187827 |
110 | Lipoatrophy (HP:0100578) | 1.94592747 |
111 | Fasciculations (HP:0002380) | 1.93624188 |
112 | Limb-girdle muscle atrophy (HP:0003797) | 1.93287121 |
113 | Birth length less than 3rd percentile (HP:0003561) | 1.93038629 |
114 | Gout (HP:0001997) | 1.92822883 |
115 | Emotional lability (HP:0000712) | 1.92231729 |
116 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92217696 |
117 | Progressive neurologic deterioration (HP:0002344) | 1.92173959 |
118 | Hyperammonemia (HP:0001987) | 1.89708807 |
119 | Microglossia (HP:0000171) | 1.89194950 |
120 | Abnormal number of erythroid precursors (HP:0012131) | 1.88732081 |
121 | Neck muscle weakness (HP:0000467) | 1.87398964 |
122 | Abnormality of serum amino acid levels (HP:0003112) | 1.86949190 |
123 | Lethargy (HP:0001254) | 1.86251544 |
124 | Sudden death (HP:0001699) | 1.84837590 |
125 | Achilles tendon contracture (HP:0001771) | 1.84471291 |
126 | Spastic paraparesis (HP:0002313) | 1.84091171 |
127 | Abnormal protein glycosylation (HP:0012346) | 1.83347177 |
128 | Abnormal glycosylation (HP:0012345) | 1.83347177 |
129 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83347177 |
130 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83347177 |
131 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83208014 |
132 | Premature rupture of membranes (HP:0001788) | 1.83050698 |
133 | Split foot (HP:0001839) | 1.82837056 |
134 | Osteolytic defects of the hand bones (HP:0009699) | 1.82509127 |
135 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82509127 |
136 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.81572118 |
137 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.81345811 |
138 | Gowers sign (HP:0003391) | 1.79645984 |
139 | T lymphocytopenia (HP:0005403) | 1.79075432 |
140 | Ventricular tachycardia (HP:0004756) | 1.76816425 |
141 | Secondary amenorrhea (HP:0000869) | 1.73721673 |
142 | Abnormality of T cell number (HP:0011839) | 1.73263649 |
143 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73161366 |
144 | Pancytopenia (HP:0001876) | 1.72788113 |
145 | Hypoglycemic coma (HP:0001325) | 1.72567565 |
146 | Optic disc pallor (HP:0000543) | 1.71028593 |
147 | Fatigue (HP:0012378) | 1.70643304 |
148 | Rimmed vacuoles (HP:0003805) | 1.66338283 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 3.41026554 |
2 | BUB1 | 3.38827888 |
3 | NEK1 | 3.07416277 |
4 | MUSK | 2.84421996 |
5 | ACVR1B | 2.57487198 |
6 | NME2 | 2.52430166 |
7 | TESK1 | 2.43220513 |
8 | PBK | 2.41778066 |
9 | EIF2AK1 | 2.38718888 |
10 | MAP3K12 | 2.36375703 |
11 | TXK | 2.28025485 |
12 | WEE1 | 2.19128529 |
13 | VRK2 | 2.17139868 |
14 | MAPKAPK5 | 2.14355108 |
15 | EIF2AK3 | 1.91251438 |
16 | MKNK1 | 1.78391128 |
17 | OBSCN | 1.77170571 |
18 | LIMK1 | 1.71774585 |
19 | TEC | 1.70551205 |
20 | MAP4K1 | 1.70468169 |
21 | MST1R | 1.70094412 |
22 | MKNK2 | 1.66980803 |
23 | TRIM28 | 1.66720097 |
24 | EPHB1 | 1.66299600 |
25 | PAK4 | 1.65302257 |
26 | TESK2 | 1.64350298 |
27 | TTN | 1.61038192 |
28 | CLK1 | 1.54377141 |
29 | SCYL2 | 1.51410668 |
30 | CDC7 | 1.50974956 |
31 | DYRK3 | 1.45592113 |
32 | EPHA2 | 1.44008811 |
33 | TSSK6 | 1.41158463 |
34 | PIM2 | 1.35651563 |
35 | WNK1 | 1.34542932 |
36 | PKN1 | 1.33714807 |
37 | ERBB4 | 1.32848250 |
38 | BCKDK | 1.31270380 |
39 | PLK3 | 1.29309330 |
40 | SRPK1 | 1.25405516 |
41 | OXSR1 | 1.24926900 |
42 | CCNB1 | 1.23114492 |
43 | MST4 | 1.21497659 |
44 | JAK3 | 1.19692171 |
45 | WNK4 | 1.16022583 |
46 | STK24 | 1.15162025 |
47 | VRK1 | 1.13991274 |
48 | MYLK | 1.07919896 |
49 | ADRBK2 | 1.07111960 |
50 | TRPM7 | 1.03334353 |
51 | CSNK1G3 | 1.01292699 |
52 | RPS6KA5 | 1.00906247 |
53 | RAF1 | 1.00894958 |
54 | PDK2 | 1.00482215 |
55 | IRAK1 | 0.99689319 |
56 | TAOK2 | 0.96832581 |
57 | MELK | 0.95518742 |
58 | ITK | 0.93835809 |
59 | ARAF | 0.92894887 |
60 | BRSK1 | 0.91763667 |
61 | BRSK2 | 0.91716071 |
62 | DYRK2 | 0.91587017 |
63 | TTK | 0.90776887 |
64 | LATS2 | 0.89749179 |
65 | PRKCQ | 0.88973647 |
66 | PRKD3 | 0.87865899 |
67 | IRAK4 | 0.87371707 |
68 | PDK3 | 0.86273826 |
69 | PDK4 | 0.86273826 |
70 | GRK7 | 0.85500391 |
71 | PLK4 | 0.83911306 |
72 | MOS | 0.81652172 |
73 | CSNK1A1L | 0.81392855 |
74 | MET | 0.81388084 |
75 | CAMK2D | 0.81353699 |
76 | NLK | 0.80937853 |
77 | RPS6KA4 | 0.78855070 |
78 | STK10 | 0.77732146 |
79 | SIK3 | 0.76000222 |
80 | ALK | 0.75650547 |
81 | BRAF | 0.75509872 |
82 | BCR | 0.74953300 |
83 | PNCK | 0.74707063 |
84 | TNIK | 0.71472873 |
85 | PAK3 | 0.71172756 |
86 | YES1 | 0.71016480 |
87 | IRAK3 | 0.70273774 |
88 | CDK4 | 0.69174805 |
89 | KDR | 0.69139873 |
90 | STK16 | 0.68268353 |
91 | ROCK2 | 0.67925942 |
92 | MAP3K3 | 0.67905033 |
93 | ILK | 0.67346601 |
94 | CSNK1G1 | 0.67311571 |
95 | LCK | 0.67181125 |
96 | BMPR1B | 0.66338660 |
97 | BLK | 0.64615745 |
98 | MAP3K5 | 0.64150254 |
99 | CDK7 | 0.62956996 |
100 | NME1 | 0.62416875 |
101 | PHKG2 | 0.61581080 |
102 | PHKG1 | 0.61581080 |
103 | KIT | 0.60735795 |
104 | IRAK2 | 0.59938169 |
105 | CAMK2B | 0.59338645 |
106 | MAP3K8 | 0.58955300 |
107 | AURKA | 0.58948702 |
108 | LRRK2 | 0.58808028 |
109 | DAPK1 | 0.58749129 |
110 | PLK1 | 0.58682695 |
111 | CHEK1 | 0.58581928 |
112 | ERBB3 | 0.56854907 |
113 | ZAK | 0.55772746 |
114 | RPS6KB2 | 0.55712272 |
115 | CHEK2 | 0.55462593 |
116 | CSK | 0.55340587 |
117 | AKT2 | 0.54606329 |
118 | ATR | 0.54239180 |
119 | PIM1 | 0.54178523 |
120 | UHMK1 | 0.53866309 |
121 | MAPKAPK3 | 0.53777824 |
122 | FGR | 0.53140260 |
123 | PAK1 | 0.52883180 |
124 | ABL2 | 0.51601961 |
125 | MAP3K9 | 0.51173716 |
126 | EIF2AK2 | 0.50959528 |
127 | PTK2 | 0.50611404 |
128 | PRKD1 | 0.49273938 |
129 | AURKB | 0.48797443 |
130 | CSNK2A1 | 0.46207024 |
131 | IKBKB | 0.45558446 |
132 | NEK2 | 0.45372519 |
133 | CSNK2A2 | 0.45276698 |
134 | CSNK1G2 | 0.44897444 |
135 | BTK | 0.44413734 |
136 | DMPK | 0.43894807 |
137 | STK4 | 0.43674400 |
138 | CAMKK2 | 0.43670105 |
139 | CAMK2G | 0.43648591 |
140 | STK3 | 0.39042465 |
141 | TGFBR2 | 0.38843757 |
142 | PRKCI | 0.37862390 |
143 | BMX | 0.35346536 |
144 | NEK9 | 0.34413326 |
145 | ATM | 0.33620523 |
146 | STK38L | 0.25684671 |
147 | TAF1 | 0.23914755 |
148 | CDK8 | 0.23477132 |
149 | FLT3 | 0.21850634 |
150 | PRPF4B | 0.21335219 |
151 | CDK18 | 0.20896316 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.32117694 |
2 | RNA polymerase_Homo sapiens_hsa03020 | 3.04112514 |
3 | Protein export_Homo sapiens_hsa03060 | 2.97387590 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.91606771 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.90749329 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.74658931 |
7 | DNA replication_Homo sapiens_hsa03030 | 2.60886201 |
8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45120287 |
9 | Proteasome_Homo sapiens_hsa03050 | 2.43680799 |
10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.35389387 |
11 | Ribosome_Homo sapiens_hsa03010 | 2.19092651 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12122165 |
13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.10032377 |
14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.07430111 |
15 | Mismatch repair_Homo sapiens_hsa03430 | 2.06387475 |
16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01251582 |
17 | Homologous recombination_Homo sapiens_hsa03440 | 1.87381303 |
18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87142782 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.86374801 |
20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83595329 |
21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.79509916 |
22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.72804789 |
23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70167768 |
24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.68202588 |
25 | Spliceosome_Homo sapiens_hsa03040 | 1.67506872 |
26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60753869 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60212745 |
28 | Base excision repair_Homo sapiens_hsa03410 | 1.60016100 |
29 | RNA transport_Homo sapiens_hsa03013 | 1.58425180 |
30 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.54293371 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48790068 |
32 | Cell cycle_Homo sapiens_hsa04110 | 1.42080529 |
33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41783413 |
34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40703431 |
35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34884990 |
36 | Asthma_Homo sapiens_hsa05310 | 1.30591120 |
37 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.30271075 |
38 | RNA degradation_Homo sapiens_hsa03018 | 1.28992644 |
39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25000082 |
40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22820289 |
41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19428952 |
42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.18235222 |
43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15585542 |
44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11794740 |
45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11460744 |
46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09809032 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05505288 |
48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04187120 |
49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03597682 |
50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97766110 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94545436 |
52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92045954 |
53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91323484 |
54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88463453 |
55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88452011 |
56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80100921 |
57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79986017 |
58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78443653 |
59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77751074 |
60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77384900 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75479672 |
62 | Purine metabolism_Homo sapiens_hsa00230 | 0.73896914 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73049598 |
64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72076988 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71600299 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70372553 |
67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69136270 |
68 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68840915 |
69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67230894 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66645788 |
71 | Measles_Homo sapiens_hsa05162 | 0.65475157 |
72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65143029 |
73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64703064 |
74 | Legionellosis_Homo sapiens_hsa05134 | 0.64322945 |
75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64231713 |
76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63779864 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61672553 |
78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61167905 |
79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58972917 |
80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58923816 |
81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58818807 |
82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57654052 |
83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56169893 |
84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56165684 |
85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55918517 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53702365 |
87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53431268 |
88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48853421 |
89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47009835 |
90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46255122 |
91 | Shigellosis_Homo sapiens_hsa05131 | 0.45154961 |
92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43844149 |
93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43282169 |
94 | Malaria_Homo sapiens_hsa05144 | 0.42935250 |
95 | Salmonella infection_Homo sapiens_hsa05132 | 0.42658450 |
96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41166299 |
97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40994667 |
98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40895811 |
99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39710947 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38802591 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.38767770 |
102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38379321 |
103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37446064 |
104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.36915741 |
105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36399187 |
106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36386437 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36005538 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35877423 |
109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35448324 |
110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35071348 |
111 | Peroxisome_Homo sapiens_hsa04146 | 0.35027430 |
112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34943862 |
113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33975508 |
114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33351266 |
115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32912541 |
116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32181525 |
117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31539932 |
118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30001083 |
119 | Apoptosis_Homo sapiens_hsa04210 | 0.29546959 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28542590 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28181797 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27550376 |
123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26633991 |
124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26238510 |
125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24725623 |
126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23814508 |
127 | Bladder cancer_Homo sapiens_hsa05219 | 0.23608307 |
128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23038766 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18559654 |
130 | Lysosome_Homo sapiens_hsa04142 | 0.18472877 |
131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17400941 |
132 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.17386899 |
133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16477730 |
134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14486713 |
135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12950544 |
136 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12867525 |